Eli Lilly (LLY) PT Raised to $1,350 at Cantor Fitzgerald as Strong Q2 Results Likely
Strong Q2 results likely; upside potential remains.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Strong Q2 results likely; upside potential remains.
What happened, with direct paths to the underlying reporting
LLY received an analyst target update from Cantor Fitzgerald. Target $1,350; Posted price $1,211.
Target: $1,350
Posted price: $1,211
Analyst firm: Cantor Fitzgerald
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.